Active: new fund May 2025 Verified 4 Nov 2026
Dalena Capital
Seed-stage investor supporting companies that translate breakthrough science into new medicines.
- Type
- VC firm
- Location
- Palo Alto, California, United States
- Stages
- Seed
- Sectors
- Biotech, Healthtech and life sciences
- Fund size / AUM
- $5M Dalena Capital Fund I (Form D offering, 2025)
- Latest fund or filing
- 15 May 2026
- Website
- dalena.vc
Fund filings (SEC Form D)
- Latest fund on file
- Dalena Capital Fund I
- Filed
- 15 May 2026 (amendment)
- Fund size
- $5M (total offering)
- Fund vehicles filed in the last 12 months
- 1 (includes feeder and parallel vehicles)
See this fund's filings on SEC EDGAR
Contacts on file
For Dalena Capital, the paid file holds: 1 named decision-maker with roles.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Sources
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 26 lists
Biotech investors in Silicon Valley (48)Biotech investors in the San Francisco Bay Area (88)Healthtech investors in Silicon Valley (91)Biotech investors in California (108)Seed investors in Silicon Valley (152)Seed biotech investors in the US (159)Healthtech investors in the San Francisco Bay Area (182)Healthtech investors in California (240)Emerging VC managers in the US (274)Biotech venture capital firms in the US (297)Seed biotech investors (300)Seed investors in the San Francisco Bay Area (324)Venture capital firms in Silicon Valley (341)Seed investors in California (415)Seed healthtech investors in the US (437)Biotech investors (484)Micro VC firms in the US (526)Healthtech venture capital firms in the US (709)Venture capital firms in the San Francisco Bay Area (768)Seed healthtech investors (800)Venture capital firms in California (1,038)Seed investors in the US (1,043)Healthtech investors (1,207)Active venture capital firms in the US (1,574)Seed investors (1,892)Venture capital firms in the US (2,975)